Clinical Trial Update: Study of LW402 in Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Clinical trial update announcing completion of a Phase 2 study of LW402 for moderate-to-severe atopic dermatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LW402

Snippet

Sponsor: Shanghai Longwood Biopharmaceuticals Co., Ltd. | Conditions: Atopic Dermatitis (AD) | Phase 2 | Status: COMPLETED